aid: cadence-neuroscience
name: Cadence Neuroscience
description: 'Cadence Neuroscience, Inc. is a clinical-stage medical device company founded in 2017 and
  headquartered in Redmond, Washington, developing a personalized neuromodulation system for pediatric
  and adult patients with focal drug-resistant epilepsy. Its implantable system, licensed from Mayo Clinic
  and incubated by a Mayo Clinic Rochester neurology and neurosurgery team, delivers chronic subthreshold
  cortical stimulation and detects EEG biomarkers of epileptiform activity in order to reduce or eliminate
  seizures. The company raised a $15M Series A in 2019 and a $26M Series B in 2023 led by the Angelini Lumira
  Biosciences Fund, with participation from F-Prime Capital, LivaNova USA, Angelini Ventures, Spectrum
  Financial Services and Mayo Clinic, and is using the proceeds to complete pivotal clinical studies and
  pursue FDA clearance. It is a regulated medical device manufacturer rather than a software vendor: it
  publishes no developer portal, public API, SDK or machine-readable API contract.'
url: https://raw.githubusercontent.com/api-evangelist/cadence-neuroscience/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-08'
modified: '2026-08-08'
tags:
- Company
- Medical Devices
- Health Care
- Neurotechnology
- Neuromodulation
- Epilepsy
- Medical Technology
- Clinical Stage
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/cadence-neuroscience-domain-security.yml
- type: Website
  url: https://cadenceneuro.com/
- type: LinkedIn
  url: https://www.linkedin.com/company/cadence-neuroscience-inc
- type: Crunchbase
  url: https://www.crunchbase.com/organization/cadence-neuroscience
- type: SecondaryMarket
  url: https://www.nasdaqprivatemarket.com/
x-enrichment:
  date: '2026-08-08'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: blocked
  reason: bot-challenge
  detail: 'Every path on cadenceneuro.com — homepage, /llms.txt and all /.well-known/*
    probes — answered HTTP 202 with a SiteGround anti-bot interstitial (a 169-byte meta-refresh
    to /.well-known/sgcaptcha/ carrying the sg-captcha challenge header) instead of the
    page, so not one page of the company''s own surface could be read; DNS/TLS probes
    and third-party sources still completed.'
  evidence:
  - url: https://cadenceneuro.com/
    status: 202
  - url: https://cadenceneuro.com/llms.txt
    status: 202
  - url: https://cadenceneuro.com/.well-known/security.txt
    status: 202
  - url: https://cadenceneuro.com/.well-known/agent-card.json
    status: 202
  checked: '2026-08-08'